首页>投融资
Perfuze
未公开
Perfuze Limited operates as a medical device company. The Company produces and develops catheter-based technology to treat acute ischemic stroke.In February 2022, Perfuze closed a €22.5 million Series A investment round
基本信息
-
公司全称Perfuze Ltd
-
类型医疗设备研发商
-
产业领域医疗器械
-
公司人数15人以下
-
地址Unit 6 Galway Business Park Dangan Galway GALWAY GALWAY H91 W7CP; IE;
-
联系电话
-
邮箱info@pefuze.com
-
成立时间2018-01-01
投融资
-
2025-03-14未公开2200万欧元EQT PartnersSeroba Life SciencesSV Health InvestorsEarlybird Venture Capital
-
2022-02-09A轮2250万欧元Life Sciences PartnersSeroba Life SciencesSV Health Investors
-
2019-01-29种子轮300万欧元MedFocus FundEnterprise IrelandEarlybird Venture Capital
相关投融资企业
E~PreIPO
Cardiac Dimensions is a medical device company developing tools and techniques for the treatment of heart failure and related conditions.In January 2023, Cardiac Dimensions Inc closed a $35 million Series D financing round co-led by Horizon 3 Healthcare
未公开
Perfuze Limited operates as a medical device company. The Company produces and develops catheter-based technology to treat acute ischemic stroke.In February 2022, Perfuze closed a €22.5 million Series A investment round
B轮
Neuromod Devices Limited is an Irish medical device company specializing in the treatment of tinnitus.In April 2023, Neuromod Devices Ltd closed a 30 million financing to further commercialise its tinnitus treatment device.In October 2020, the company had closed series B oversubscribed by 10.5 million euros raise Lenire tinnitus treatment device
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息